NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

兒童疫苗的全球市場:未來預測

Pediatric Vaccines Market - Global Forecast to 2026

出版商 Coherent Market Insights 商品編碼 664177
出版日期 內容資訊 英文 189 Pages
商品交期: 2-3個工作天內
價格
兒童疫苗的全球市場:未來預測 Pediatric Vaccines Market - Global Forecast to 2026
出版日期: 2018年05月31日內容資訊: 英文 189 Pages
簡介

本報告提供全球兒童用疫苗的市場相關分析,市場基本結構和背景情況 (相關疾病概要,法規資訊等),主要的推動及阻礙市場要素,整體市場規模趨勢預測 (今後10年份),疫苗類別·各流通管道·各地區的詳細趨勢,主要企業的簡介與業績,今後的市場方向性等調查。

第1章 分析目的與前提條件

第2章 市場概要

  • 分析概要
  • 摘要整理
  • COM (Coherent Opportunity Map:市場機會藍圖)

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 市場趨勢
  • 流行病學的趨勢
  • 近幾年主要的動向
    • 認知度提高策略
    • 企業合併·收購 (M&A)
    • 法規方案
    • 新產品的認證/上市
  • PEST分析
  • 波特的五力分析

第4章 全球兒童疫苗市場:疫苗類別

  • 簡介
    • 市場佔有率分析 (最新值·預測值)
    • 年度成長率分析 (今後10年份)
    • 各部門分析
  • 單價疫苗
    • 簡介
    • 市場規模與其預測,年度成長率 (以金額為準,今後11年份)
  • 多價疫苗

第5章 全球兒童疫苗市場:疫苗的不同形狀

  • 簡介
  • 弱毒生病毒
  • 不活化病毒
  • 次單元
  • 類毒素
  • 基因改造疫苗
  • 多糖體
  • 結合型疫苗

第6章 全球兒童疫苗市場:各用途

  • 簡介
  • 感染疾病用
  • 過敏用

第7章 全球兒童疫苗市場:各終端用戶

  • 簡介
  • 醫院
  • 小兒科診所
  • 教育·研究機關
  • 其他

第8章 全球兒童疫苗市場:各地區

  • 簡介
  • 北美市場 (美國,加拿大)
    • 市場規模與其預測,疫苗類別 (以金額為準,總計11年份)
    • 市場規模與其預測,疫苗的不同形狀 (以金額為準,總計11年份)
    • 市場規模與其預測,各用途 (以金額為準,總計11年份)
    • 市場規模與其預測,各國 (以金額為準,總計11年份)
  • 歐洲市場 (英國,德國,義大利,西班牙,法國,俄羅斯等)
  • 亞太地區市場 (中國,日本,印度,東南亞國協,澳洲,韓國等)
  • 南美市場 (巴西,墨西哥,阿根廷等)
  • 非洲市場 (北部非洲,中部非洲,南非)
  • 中東市場 (波灣合作理事會 (GCC) 各國,以色列等)

第9章 競爭環境

  • 熱圖分析
  • 企業簡介
    • GlaxoSmithKline plc
    • Serum Institute of India Pvt. Ltd.
    • Eli Lilly Company
    • AstraZeneca plc
    • Pfizer, Inc.
    • Aventis Pharma Limited
    • Indian Immunologicals Limited
    • Zydus Cadila
    • Panacea Drugs Pvt. Ltd.
    • Sinovac Biotech Ltd.

第10章 附錄

目錄

Report Description

  • Pediatric vaccines are revolutionizing the healthcare industry by providing protection against the severe illnesses, thereby enabling improved heath and reduced family stress. Moreover, childhood immunization is essential step in maintaining high vaccination levels within the population, which prevents outbreaks such as diphtheria, hepatitis A, hepatitis B, influenza, Haemophilus influenzae type b (Hib), measles, and mumps. Various government healthcare organizations such as the United Nations Children's Fund (UNICEF), American Academy of Pediatrics (AAP), and World Health Organization (WHO) are engaged in initiating various immunization awareness programmes to increase vaccination among the pediatric population.

Market Dynamics

  • The Centers for Disease Control and Prevention (CDC) recommends immunizing children against most of the vaccine preventable disease by the time they are two years old. These resulted in elimination of some of the infectious disease completely in various countries. For instance, Polio and smallpox have been eliminated in the U.S. due to effective vaccination. In March 2014, World Health Organisation (WHO) declared India as polio-free nation.
  • Increasing prevalence of chronic and infectious disease, along with growing awareness regarding childhood immunization among various developed and emerging economies lead to boost the growth of pediatric vaccines market in near future. Furthermore, increasing alliances, partnership, and collaborations among key players to introduce
  • efficient vaccines in the market is expected to drive growth of the market in near future.

Key features of the study:

  • This report provides in-depth analysis of pediatric vaccines and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global pediatric vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Eli Lilly Company, AstraZeneca plc, Pfizer, Inc., Aventis Pharma Limited, Indian Immunologicals Limited, Zydus Cadila, Panacea Drugs Pvt. Ltd., and Sinovac Biotech Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, pediatric vaccine manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Global Pediatric Vaccines Market, By Vaccine Type:
  • Monovalent
  • Multivalent
  • Global Pediatric Vaccines Market, By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • Global Pediatric Vaccines Market, By Application:
  • Infectious Disease
  • Allergy
  • Global Pediatric Vaccines Market, By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Global Pediatric Vaccines Market, By Geography:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Europe
    • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Rest of Asia Pacific
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Africa
    • By Country:
  • South Africa
  • Central Africa
  • North Africa
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Company Profiles
  • GlaxoSmithKline plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
  • Serum Institute of India Pvt. Ltd.
  • Eli Lilly Company
  • AstraZeneca plc
  • Pfizer, Inc.
  • Aventis Pharma Limited
  • Indian Immunologicals Limited
  • Zydus Cadila
  • Panacea Drugs Pvt. Ltd.
  • Sinovac Biotech Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Vaccine Type
    • Market Snippet By Vaccine Form
    • Market Snippet By Application
    • Market Snippet By End-User
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Market Trends
    • Epidemiology
    • Key Developments
    • Awareness Strategies
    • Merger and Acquisitions
    • Regulatory Scenario
    • New Product Approvals/Launch
    • PEST Analysis
    • Porter's Analysis

4. Global Pediatric Vaccines Market, By Vaccine Type, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Monovalent
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Multivalent
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

5. Global Pediatric Vaccines Market, By Vaccine Form, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Attenuated Live Viruses
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Inactivated Viruses
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Subunits
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Toxoids
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Recombinant
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Polysaccharides
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Conjugates
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

6. Global Pediatric Vaccines Market, By Application, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Infectious Disease
    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
  • Allergy
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

7. Global Pediatric Vaccines Market, By End-User, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Pediatric Clinics
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Academic & Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

8. Global Pediatric Vaccines Market, By Regions, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, For Regions, 2017 - 2026
  • North America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Eli Lilly Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Aventis Pharma Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Indian Immunologicals Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Zydus Cadila
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Panacea Drugs Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Sinovac Biotech Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact